WDB coco Co (TSE:7079) Cash And Cash Equivalents : 円2,264 Mil (As of Dec. 2023)

View and export this data going back to 2019. Start your Free Trial

What is WDB coco Co Cash And Cash Equivalents?

WDB coco Co's quarterly cash and cash equivalents increased from Jun. 2023 (円1,984.96 Mil) to Sep. 2023 (円2,185.85 Mil) and increased from Sep. 2023 (円2,185.85 Mil) to Dec. 2023 (円2,264.23 Mil).

WDB coco Co's annual cash and cash equivalents increased from Mar. 2021 (円1,280.27 Mil) to Mar. 2022 (円1,888.59 Mil) and increased from Mar. 2022 (円1,888.59 Mil) to Mar. 2023 (円2,001.90 Mil).

WDB coco Co Cash And Cash Equivalents Historical Data

The historical data trend for WDB coco Co's Cash And Cash Equivalents can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

WDB coco Co Cash And Cash Equivalents Chart

WDB coco Co Annual Data

Trend

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Cash And Cash Equivalents

Get a 7-Day Free Trial

496.43

1,031.13

1,280.27

1,888.59

2,001.90

WDB coco Co Quarterly Data
	Mar18	Mar19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Cash And Cash Equivalents	Get a 7-Day Free Trial															1,973.40	2,001.90	1,984.96	2,185.85	2,264.23

WDB coco Co Cash And Cash Equivalents Calculation

Cash and cash equivalents are the most liquid assets on the balance sheet. Cash equivalents are assets that are readily convertible into cash, such as money market holdings, short-term government bonds or Treasury bills, marketable securities and commercial paper.

WDB coco Co (TSE:7079) Cash And Cash Equivalents Explanation

A high number means either:

1) The company has competitive advantage generating lots of cash

2) Just sold a business or bonds (not necessarily good)

A low stockpile of cash usually means poor to mediocre economics.

There are 3 ways to create large cash reserve.

1) Sell new bonds or equity to public

2) Sell business or asset

3) It has an ongoing business generating more cash than it burns (usually means durable competitive advantage)

When a company is suffering a short term problem, Buffett looks at cash or marketable securities to see whether it has the financial strength to ride it out.

Important: Lots of cash and marketable securities + little debt = good chance that the business will sail on through tough times.

Test to see what is creating cash by looking at past 7 yrs of balance sheets. This will reveal how the cash was created.

Be Aware

Depreciation estimates make the calculation of net income susceptible to management's accounting choices. These choices can be either overly aggressive or overly conservative.

WDB coco Co Cash And Cash Equivalents Related Terms

Thank you for viewing the detailed overview of WDB coco Co's Cash And Cash Equivalents provided by GuruFocus.com. Please click on the following links to see related term pages.

WDB coco Co (TSE:7079) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » WDB coco Co Ltd (TSE:7079) » Definitions » Cash And Cash Equivalents

Comparable Companies

Traded in Other Exchanges

N/A

Address

1-8-11 Harumi, Chuo-ku, Triton Square Y 27th Floor, Tokyo, JPN, 104-6127

Website

https://www.wdbcoco.com

WDB coco Co Ltd is a provider of safety information management for the development of pharmaceuticals and medical devices. Its services include business related to safety information management, preparation of materials related to regulatory application, QC related work, PMS facility contract support related work, clinical research support / monitoring, and temporary staffing. The company provides Contract Research Organization services for all new drug developments such as monitoring, safety information, data management and statistical analysis. It provides support for the development of generic drugs such as bioequivalence studies and biosimilars, clinical research and physician-led clinical trials.

WDB coco Co (TSE:7079) Headlines

No Headlines